Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increase in prevalence of liver diseases
3.2.1.2 Rise in smoking, alcohol and drug consumption
3.2.1.3 Technological advancements in diagnostic kits
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of diagnostic tests
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursemnt scenario
3.6 Future market trends
3.7 Technological landscape
3.8 Porter's analysis
3.8.1 Supplier power
3.8.2 Buyer power
3.8.3 Threat of new entrants
3.8.4 Threat of substitutes
3.8.5 Industry rivalry
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Disease Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Hepatitis
5.3 Cirrhosis
5.4 Liver cancer
5.5 Non-alcoholic fatty liver disease (NAFLD)
5.6 Other disease types
Chapter 6 Market Estimates and Forecast, By Technique, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Imaging
6.3 Liver biopsy
6.4 Endoscopy
6.5 Laboratory tests
Chapter 7 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Laboratories
7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 BioMerieux SA
9.3 Bio-Rad Laboratories Inc.
9.4 Cosara Diagnostics Pvt Ltd.
9.5 F. Hoffmann-La Roche Ltd.
9.6 HORIBA Medical
9.7 Laboratory Corporation of America Holdings
9.8 Meril Life Sciences Pvt. Ltd.
9.9 Qiagen N.V.
9.10 Siemens Healthcare GmbH
9.11 Thermo Fisher Scientific Inc.
